ZyVersa Therapeutics, Inc.
ZVSA
$0.20
$0.014.17%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -80.72% | 632.32% | -95.53% | 5.26% | 1,145.65% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.33% | -21.26% | -24.08% | 169.77% | -30.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -91.44% | 72.51% | -- | -- | -- |
| Total Current Assets | -65.05% | 81.30% | -73.98% | 22.99% | 339.50% |
|
|
|||||
| Total Current Assets | -65.05% | 81.30% | -73.98% | 22.99% | 339.50% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -89.93% | 95.38% | -3.56% | -38.87% |
| Total Assets | -66.56% | -94.70% | -6.41% | 1.87% | 6.05% |
|
|
|||||
| Total Accounts Payable | 3.25% | 0.32% | 1.77% | 2.86% | 0.57% |
| Total Accrued Expenses | -11.90% | -0.60% | 21.60% | 26.76% | -16.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -7.86% | 858.90% | 0.00% | 0.00% | 0.00% |
| Total Other Current Liabilities | -7.86% | 858.90% | 0.00% | 0.00% | 0.00% |
| Total Current Liabilities | -0.24% | 0.60% | 5.72% | 6.88% | -2.69% |
|
|
|||||
| Total Current Liabilities | -0.24% | 0.60% | 5.72% | 6.88% | -2.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00% | 0.00% | -0.34% |
| Total Liabilities | -0.24% | -5.73% | 5.34% | 6.39% | -2.53% |
|
|
|||||
| Common Stock & APIC | 0.01% | 1.61% | 0.15% | 1.54% | 2.46% |
| Retained Earnings | -0.50% | -16.91% | -1.92% | -2.00% | -1.28% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -5.64% | -292.23% | -24.97% | -4.53% | 21.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.64% | -292.23% | -24.97% | -4.53% | 21.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.64% | -292.23% | -24.98% | -4.53% | 21.19% |
|
|
|||||